Huapont Life Sciences Co.,Ltd. (SHE:002004)

Huapont Life Sciences Balance Sheet

Financials in millions CNY. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Jan 1, 2023	Jan 1, 2022	Jan 1, 2021
Cash & Equivalents	2,957	3,290	3,783	4,187	4,386	4,122
Short-Term Investments	-	1,556	1,197	799.5	605.52	-
Trading Asset Securities	1,076	653.87	630.28	706.29	1,030	862.27
Cash & Short-Term Investments	4,033	5,500	5,610	5,692	6,022	4,985
Cash Growth	-4.78%	-1.97%	-1.44%	-5.47%	20.81%	6.30%
Accounts Receivable	3,112	2,554	2,048	2,294	2,676	2,196
Other Receivables	593.53	579	681.23	583.37	666.99	401.89
Receivables	3,706	3,133	2,729	2,877	3,343	2,598
Inventory	2,010	2,253	2,675	2,536	2,402	1,951
Prepaid Expenses	-	-	-	3.88	14.94	-
Other Current Assets	1,677	390.25	373.77	445.45	531.85	1,269
Total Current Assets	11,426	11,277	11,387	11,554	12,314	10,803
Property, Plant & Equipment	9,683	9,925	10,051	8,920	7,973	7,922
Long-Term Investments	2,432	2,474	2,894	2,940	2,534	2,605
Goodwill	2,032	2,032	2,740	2,948	3,440	3,465
Other Intangible Assets	1,559	1,526	1,599	1,733	1,724	1,643
Long-Term Deferred Tax Assets	505.54	525.93	434.04	342.15	266.23	354.99
Long-Term Deferred Charges	483.06	575.07	540.53	558.56	570.14	323.71
Other Long-Term Assets	1,124	1,116	1,082	1,033	1,218	1,147
Total Assets	29,244	29,450	30,727	30,029	30,040	28,263
Accounts Payable	1,811	2,266	2,703	2,375	2,439	1,759
Accrued Expenses	195	403.62	398.82	1,728	1,556	329.25
Short-Term Debt	2,950	3,561	4,666	4,576	5,493	7,409
Current Portion of Long-Term Debt	1,555	2,318	1,016	1,678	1,192	-
Current Portion of Leases	-	13.98	12.62	9.52	9.44	-
Current Income Taxes Payable	241.7	159.24	121.68	245.78	170.38	125.24
Current Unearned Revenue	151.07	225.51	201.39	304.6	383.17	284.55
Other Current Liabilities	1,622	1,468	1,515	193.96	146.13	1,816
Total Current Liabilities	8,527	10,415	10,634	11,112	11,389	11,723
Long-Term Debt	3,986	2,943	2,884	1,742	2,222	1,839
Long-Term Leases	50.16	53.42	47.62	41.9	51.62	34.87
Long-Term Unearned Revenue	289.66	266.87	271.23	278.21	258.13	224.94
Long-Term Deferred Tax Liabilities	100.41	104.62	111.64	109.84	103.4	108.31
Other Long-Term Liabilities	193.15	193.84	193.95	194.63	196.68	196.8
Total Liabilities	13,146	13,977	14,143	13,478	14,221	14,126
Common Stock	1,980	1,980	1,980	1,980	1,980	1,980
Additional Paid-In Capital	5,434	5,304	5,290	5,249	5,214	4,885
Retained Earnings	2,401	2,183	2,920	3,050	3,089	2,857
Treasury Stock	-30	-30	-	-	-	-
Comprehensive Income & Other	-85.25	-100.67	-84.95	-87.55	-176.15	-92.77
Total Common Equity	9,699	9,337	10,105	10,192	10,107	9,629
Minority Interest	6,400	6,136	6,480	6,359	5,712	4,507
Shareholders' Equity	16,099	15,473	16,585	16,551	15,819	14,137
Total Liabilities & Equity	29,244	29,450	30,727	30,029	30,040	28,263
Total Debt	8,541	8,890	8,626	8,048	8,968	9,283
Net Cash (Debt)	-4,508	-3,390	-3,016	-2,355	-2,946	-4,298
Net Cash Per Share	-2.28	-1.72	-1.52	-1.19	-1.49	-2.18
Filing Date Shares Outstanding	1,973	1,973	1,976	1,980	1,980	1,980
Total Common Shares Outstanding	1,973	1,973	1,980	1,980	1,980	1,980
Working Capital	2,899	861.64	753.65	442.59	924.82	-919.78
Book Value Per Share	4.92	4.73	5.10	5.15	5.10	4.86
Tangible Book Value	6,107	5,779	5,766	5,511	4,943	4,522
Tangible Book Value Per Share	3.10	2.93	2.91	2.78	2.50	2.28
Buildings	-	5,919	5,626	5,120	4,570	4,509
Machinery	-	8,462	7,632	6,765	6,051	5,492
Construction In Progress	-	1,154	1,869	1,434	1,464	1,532

Source: S&P Global Market Intelligence. Standard template. Financial Sources.